Track topics on Twitter Track topics that are important to you
PredictImmune has secured £4.3m investment from Wellcome Trust to assess the clinical utility of its prognostic test In Crohn’s disease.
PredictImmune has been awarded £4.3M (€4.8M) by the Wellcome Trust to run a clinical trial with its prognostic biomarker test for Crohn’s disease. UK biotech PredictImmune, a developer of pr...
Paul Kinnon appointed to drive the company’s next phase of development - commercialisation and expansion PredictImmune, a developer of pioneering prognostic products for gui...
PredictImmune, a developer of prognostic tools to guide treatment of patients with immune-mediated diseases, announced today that it has been awarded £4.3m by the Wellcome Trust....
We have published hundreds of PredictImmune news stories on BioPortfolio along with dozens of PredictImmune Clinical Trials and PubMed Articles about PredictImmune for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of PredictImmune Companies in our database. You can also find out about relevant PredictImmune Drugs and Medications on this site too.